EFM
GOSS icon

E Fund Management’s Gossamer Bio GOSS Stock Holding History

E Fund Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-145,237
Closed -$315K – 342
2022
Q4 		$315K Buy
145,237
+129,468
+821% +$1.07M 0.03% 223
2022
Q3 		$189K Sell
15,769
-650
-4% -$8.07K 0.02% 310
2022
Q2 		$137K Buy
+16,419
New +$127K 0.01% 314

Other funds holding GOSS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

E Fund Management's GOSS Position: Q1 2023 in Review

E Fund Management sold out of Gossamer Bio (GOSS) in Q1 2023, closing a stake of 145,237 shares — an estimated $315K sold.

E Fund Management first reported a position in GOSS in Q2 2022 and held it in 3 quarters. The position peaked at $315K in Q4 2022. 111 funds tracked by Wall St. Rank hold GOSS as of Q1 2023.

  • E Fund Management reported no remaining Gossamer Bio position as of Q1 2023 after selling out during the quarter.
  • E Fund Management sold 145,237 Gossamer Bio shares in Q1 2023, an estimated $315K.
  • E Fund Management first reported a position in Gossamer Bio in Q2 2022 and held it in 3 quarters.
  • E Fund Management's Gossamer Bio position peaked at $315K in Q4 2022.
  • 111 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2023.

Based on E Fund Management's 13F filing for Q1 2023, filed 11 May 2023.